Association of ERα-36 expression with the de novo resistance of tamoxifen in ER-positive breast cancer

MLA

Indra Indra, et al. “Association of ERα-36 Expression with the de Novo Resistance of Tamoxifen in ER-Positive Breast Cancer.” Breast Disease, vol. 40, no. S1, June 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....635eb8630d32ed85a9c82dc656c9058c&authtype=sso&custid=ns315887.

APA

Indra Indra, Berti Nelwan, Prihantono Prihantono, Septiman Rahman, & Amir Juliansyah. (2021). Association of ERα-36 expression with the de novo resistance of tamoxifen in ER-positive breast cancer. Breast Disease, 40(S1).

Chicago

Indra Indra, Berti Nelwan, Prihantono Prihantono, Septiman Rahman, and Amir Juliansyah. 2021. “Association of ERα-36 Expression with the de Novo Resistance of Tamoxifen in ER-Positive Breast Cancer.” Breast Disease 40 (S1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....635eb8630d32ed85a9c82dc656c9058c&authtype=sso&custid=ns315887.